Ospemifene,* a novel selective estrogen receptor modulator, appears to be beneficial for postmenopausal women with vaginal atrophy,

Vaginal Atrophy ◽

Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women

The American Journal of Cardiology ◽

10.1016/s0002-9149(00)01116-4 ◽

2000 ◽

Vol 86 (8) ◽

pp. 892-895 ◽

Cited By ~ 34

Author(s):

Arnon Blum ◽

William H Schenke ◽

Londa Hathaway ◽

Rita Mincemoyer ◽

Gyorgy Csako ◽

...

Keyword(s):

Estrogen Receptor ◽

Postmenopausal Women ◽

Receptor Modulator ◽

Markers Of Inflammation

Cardiovascular Effects of Droloxifene, a New Selective Estrogen Receptor Modulator, in Healthy Postmenopausal Women

Arteriosclerosis Thrombosis and Vascular Biology ◽

10.1161/01.atv.20.6.1606 ◽

2000 ◽

Vol 20 (6) ◽

pp. 1606-1612 ◽

Cited By ~ 34

Author(s):

David M. Herrington ◽

Benjamin E. Pusser ◽

Ward A. Riley ◽

Tom Y. Thuren ◽

K. Bridget Brosnihan ◽

...

Keyword(s):

Estrogen Receptor ◽

Postmenopausal Women ◽

Cardiovascular Effects ◽

Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM)

Menopause The Journal of The North American Menopause Society ◽

10.1097/01.wcb.0000121484.18437.98 ◽

2004 ◽

Vol 11 (5) ◽

pp. 508-518 ◽

Cited By ~ 83

Author(s):

Stephan Christgau ◽

L??szl?? B. Tank?? ◽

Paul A. C. Cloos ◽

Ulrik Mouritzen ◽

Claus Christiansen ◽

...

Keyword(s):

Estrogen Receptor ◽

Postmenopausal Women ◽

Ovariectomized Rats ◽

Receptor Modulator ◽

Cartilage Turnover

Selective Estrogen Receptor Modulator Effects on Serum Lipoproteins and Vascular Function in Postmenopausal Women and in Hypercholesterolemic Men

Annals of the New York Academy of Sciences ◽

10.1111/j.1749-6632.2001.tb04016.x ◽

2006 ◽

Vol 949 (1) ◽

pp. 168-174 ◽

Cited By ~ 13

Author(s):

ARNON BLUM ◽

RICHARD O. CANNON

Keyword(s):

Estrogen Receptor ◽

Postmenopausal Women ◽

Vascular Function ◽

Serum Lipoproteins ◽

Endometrial Effects of Bazedoxifene Acetate, a Novel Selective Estrogen Receptor Modulator, in Postmenopausal Women

Obstetrics and Gynecology ◽

10.1097/01.aog.0000186081.62399.61 ◽

2005 ◽

Vol 106 (5, Part 1) ◽

pp. 1110-1111 ◽

Cited By ~ 1

Author(s):

Michael W. Draper ◽

Leo Plouffe

Keyword(s):

Estrogen Receptor ◽

Postmenopausal Women ◽

Ospemifene: A first-in-class, non-hormonal selective estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar and vaginal atrophy

Steroids ◽

10.1016/j.steroids.2014.07.012 ◽

2014 ◽

Vol 90 ◽

pp. 82-93 ◽

Cited By ~ 24

Author(s):

Michael W. DeGregorio ◽

Robert L. Zerbe ◽

Gregory T. Wurz

Keyword(s):

Estrogen Receptor ◽

Vaginal Atrophy ◽

Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia

Psychoneuroendocrinology ◽

10.1016/j.psyneuen.2010.01.014 ◽

2010 ◽

Vol 35 (8) ◽

pp. 1142-1147 ◽

Cited By ~ 80

Author(s):

Jayashri Kulkarni ◽

Caroline Gurvich ◽

Stuart J. Lee ◽

Heather Gilbert ◽

Emmy Gavrilidis ◽

...

Keyword(s):

Estrogen Receptor ◽

Postmenopausal Women ◽

Therapeutic Dose ◽

Endometrial Effects of Bazedoxifene Acetate, a Novel Selective Estrogen Receptor Modulator, in Postmenopausal Women

Obstetrics and Gynecology ◽

10.1097/01.aog.0000163253.27610.b9 ◽

2005 ◽

Vol 105 (6) ◽

pp. 1397-1404 ◽

Cited By ~ 81

Author(s):

Sheila Ronkin ◽

Robert Northington ◽

Edmund Baracat ◽

Márcia G. Nunes ◽

David F. Archer ◽

...

Keyword(s):

Estrogen Receptor ◽

Postmenopausal Women ◽

Faculty of 1000 evaluation for Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718173140.793487367 ◽

2013 ◽

Author(s):

Parvaneh Mohammadkhani

Keyword(s):

Estrogen Receptor ◽

Vaginal Atrophy ◽

The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: A randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2005.02.083 ◽

2005 ◽

Vol 193 (4) ◽

pp. 1384-1394 ◽

Cited By ~ 6

Author(s):

Tatjana E. Vogelvang ◽

Velja Mijatovic ◽

Peter Kenemans ◽

Jef J. Emeis ◽

Johannes A. Heijst ◽

...

Keyword(s):

Estrogen Receptor ◽

Postmenopausal Women ◽

Double Blind ◽

Receptor Modulator ◽

Dose Ranging ◽

Coagulation And Fibrinolysis